Results 241 to 250 of about 573,336 (261)

Transcriptomic profiling of thyroid eye disease orbital fibroblasts identifies sorafenib as a novel therapeutic. [PDF]

Front Endocrinol (Lausanne)
Yuan K, Truong P, Patrick CC, Ushchak E, Roztocil E, Feldon SE, Woeller CF.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming

Cancer Cell, 2016
Irène Bertolini, M Cecilia Caíno, Lucia Languino   +2 more
exaly  

Akt in cancer: Mediator and more

Seminars in Cancer Biology, 2019
Munirajan A K
exaly  

Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology

Journal of Neurochemistry, 2005
Peter Dockery, Cora O'Neill, Rosemary O'Connor   +2 more
exaly  

Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor

Annals of Oncology, 2005
Mototsugu Oya
exaly  

Role of Akt Signaling in Vascular Homeostasis and Angiogenesis

Circulation Research, 2002
Kenneth Walsh
exaly  

PI3K/Akt and apoptosis: size matters

Oncogene, 2003
Christoph Horník, Thomas F Franke, Chizuru Sugimoto   +2 more
exaly  

Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients

British Journal of Cancer, 2006
Cecile le Page
exaly  

The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases

Annals of Oncology, 2014
C H Maeng, M K Choi, S H Jung
exaly  

Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt

International Journal of Cancer, 2009
Peter K Vogt
exaly